Log in to save to my catalogue

Thymopoietin‐ α , ‐ β , and ‐ γ Isoforms Increased Expression in Cervical Cancer Cells

Thymopoietin‐ α , ‐ β , and ‐ γ Isoforms Increased Expression in Cervical Cancer Cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a82ae70a88df4cefba6166dd942833b4

Thymopoietin‐ α , ‐ β , and ‐ γ Isoforms Increased Expression in Cervical Cancer Cells

About this item

Full title

Thymopoietin‐ α , ‐ β , and ‐ γ Isoforms Increased Expression in Cervical Cancer Cells

Publisher

United States: John Wiley & Sons, Inc

Journal title

The Canadian journal of infectious diseases & medical microbiology, 2025-01, Vol.2025 (1), p.1668482

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Cervical cancer (CC) is a public health concern related to the human papillomavirus (HPV) persistent infection. Minichromosome maintenance 2 (MCM2) has been postulated as a surrogate marker for HPV infection. Thymopoietin (TMPO) is a nuclear protein regulated by E2F such as MCM2 or p16. TMPO can give rise to six different isoforms. Herein, both the...

Alternative Titles

Full title

Thymopoietin‐ α , ‐ β , and ‐ γ Isoforms Increased Expression in Cervical Cancer Cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a82ae70a88df4cefba6166dd942833b4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a82ae70a88df4cefba6166dd942833b4

Other Identifiers

ISSN

1712-9532

E-ISSN

1918-1493

DOI

10.1155/cjid/1668482

How to access this item